Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Controlled Substances topic
No spam. Unsubscribe anytime.
Nevada Board of Pharmacy adopts rule adding two synthetic opioids to Schedule I
Summary
The Nevada State Board of Pharmacy voted unanimously June 4 to add N-pyrrolidino metonitazene and N-pyrrolidino protonitazene to Schedule I (LCB File No. R038-26), citing public-safety concerns; there was no public comment at the hearing.
The Nevada State Board of Pharmacy voted unanimously on June 4 to adopt LCB File No. R038-26, a regulation that places N-pyrrolidino metonitazene and N-pyrrolidino protonitazene on Schedule I.
Darla Zarley, grant and project analyst for the Board, presented the proposed NAC 453 amendment and the Board closed the public-comment period with no speakers. The motion to adopt the regulation was made by Jade Jacobo, seconded by Krystal Freitas, and passed unanimously. The file number for the adopted regulation is R038-26.
Board members said the change aligns the state schedule with emerging patterns in illicit synthetic-opioid availability; the record contains no public opposition at the hearing. The adopted regulation adds the two named compounds to Schedule I under the Nevada Administrative Code governing controlled substances. The rule takes effect according to the dates specified by the administrative rulemaking process.
